Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: A leading meta-analysis

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Jin, Wenwen ^a,c   Lin, Zhonghua ^a,c   Xin, Yongning ^a,b,c   Jiang, Xiangjun ^a,c   Dong, Quanjiang ^a,c   Xuan, Shiying ^a,b,c  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

^b OCEAN UNIVERSITY OF CHINA   (China)

^c Qingdao City Key Laboratory of Digestive Diseases   (China)

Author keywords

APRI; Diagnostic accuracy; HBV; Liver fibrosis; Meta analysis

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE PLATELET RATIO INDEX; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PERFORMANCE MEASUREMENT SYSTEM; PREDICTIVE VALUE; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; AGED; BLOOD; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; REVIEW; THROMBOCYTE; VIROLOGY;

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ADULT; AGED; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD PLATELETS; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84857017520     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-14     Document Type: Article

References (37)

1. Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol 2006, 101(Suppl 1):S1-6.
2. Friedman LS. Controversies in liver biopsy: who, where, when, how, why?. Curr Gastroenterol Rep 2004, 6:30-36. 10.1007/s11894-004-0023-4, 14720451.
3. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38:1449-1457.
4. Douds AC, Joseph AE, Finlayson C, et al. Is day case liver biopsy underutilised?. Gut 1995, 37:574-575. 10.1136/gut.37.4.574, 1382913, 7489948.
5. Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986, 2:165-173. 10.1016/S0168-8278(86)80075-7, 3958472.
6. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
7. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25. 10.1186/1471-2288-3-25, 305345, 14606960.
8. Whiting P, Rutjes AW, Dinnes J, et al. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 2004, 8:1-234. iii.
9. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293. 10.1002/hep.510240201, 8690394.
10. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995, 19:1409-1417. 10.1097/00000478-199512000-00007, 7503362.
11. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991, 13:372-374. 10.1016/0168-8278(91)90084-O, 1808228.
12. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699. 10.1016/0168-8278(95)80226-6, 7560864.
13. Schmid CH, Stark PC, Berlin JA, et al. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol 2004, 57:683-697. 10.1016/j.jclinepi.2003.12.001, 15358396.
14. Wai CT, Cheng CL, Wee A, et al. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int 2006, 26:666-672. 10.1111/j.1478-3231.2006.01287.x, 16842322.
15. Xu J, Shi J, Wang YP, et al. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis. Med Sci Monit 2009, 15:CR274-279.
16. Kim do Y, Kim SU, Ahn SH, et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2009, 54:1758-1763. 10.1007/s10620-008-0541-2, 19005758.
17. Tu XL, Xiao YQ, Chen F. A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2009, 17:28-32.
18. Zhang YX, Wu WJ, Zhang YZ, et al. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol 2008, 14:7117-7121. 10.3748/wjg.14.7117, 2776843, 19084920.
19. Pissaia A, Borderie D, Bernard D, et al. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology. Transplant Proc 2009, 41:679-681. 10.1016/j.transproceed.2008.12.014, 19328955.
20. Obara N, Ueno Y, Fukushima K, et al. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol 2008, 43:720-728. 10.1007/s00535-008-2225-2, 18807134.
21. Wu SD, Wang JY, Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study. World J Gastroenterol 2010, 16:501-507. 10.3748/wjg.v16.i4.501, 2811806, 20101779.
22. Sebastiani G, Vario A, Guido M, et al. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007, 13:525-531.
23. Chrysanthos NV, Papatheodoridis GV, Savvas S, et al. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. Eur J Gastroenterol Hepatol 2006, 18:389-396. 10.1097/00042737-200604000-00012, 16538110.
24. Shin WG, Park SH, Jang MK, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis 2008, 40:267-274. 10.1016/j.dld.2007.10.011, 18055281.
25. Hongbo L, Xiaohui L, Hong K, et al. Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation. Clin Biochem 2007, 40:562-566. 10.1016/j.clinbiochem.2007.01.022, 17362902.
26. Lin CS, Chang CS, Yang SS, et al. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Intern Med 2008, 47:569-575. 10.2169/internalmedicine.47.0595, 18379139.
27. Kim BK, Kim SA, Park YN, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int 2007, 27:969-976. 10.1111/j.1478-3231.2007.01519.x, 17696936.
28. Zheng RD ZK, Xian JC, Xu HT, Chen XX, Shen YL, Mao YM, Zeng MD, Lu LG. Assessment of noninvasive diagnostic models for predicting liver fibrosis in patients with chronic hepatitis B virus infection. Chin Hepatol 2008, 13:451-455.
29. Jiang ZS WX, Ke L, Tan C, Chen N, Li MJ. The diagnostic value of APRI and Forns index for liver fibrosis of chronic hepatitis B. Chin J Clini Hepatol 2008, 24:423-425.
30. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350. 10.1053/j.gastro.2004.11.018, 15685546.
31. Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, et al. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection. Liver Int 2008, 28:486-493. 10.1111/j.1478-3231.2008.01675.x, 18339075.
32. Sinn DH, Paik SW, Kang P, et al. Disease progression and the risk factor analysis for chronic hepatitis C. Liver Int 2008, 28:1363-1369. 10.1111/j.1478-3231.2008.01860.x, 18710426.
33. Toniutto P, Fabris C, Bitetto D, et al. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol Hepatol 2007, 22:1904-1908. 10.1111/j.1440-1746.2006.04628.x, 17914968.
34. Snyder N, Gajula L, Xiao SY, et al. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol 2006, 40:535-542. 10.1097/00004836-200607000-00013, 16825937.
35. Fabris C, Smirne C, Toniutto P, et al. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index. Clin Biochem 2006, 39:339-343. 10.1016/j.clinbiochem.2006.01.011, 16487951.
36. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007, 46:912-921. 10.1002/hep.21835, 17705266.
37. Afdhal NH, Curry M. Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis. J Hepatol 2007, 46:543-545. 10.1016/j.jhep.2007.01.008, 17316879.